Low Back Pain. Pharmacologic Management

Primary Care - Clinics in Office Practice

Volumn 39, Issue 3, 2012, Pages 499-510

  Miller, Susan M ^a,b  

^a Duke/Southern Regional Area Health Education Family Medicine Residency Program   (United States)

^b University of North Carolina   (United States)

Author keywords

Evidence based practice; Low back pain; Opioid therapy; Pharmacologic treatment

Indexed keywords

ANTIDEPRESSANT AGENT; CELECOXIB; DICLOFENAC; ETODOLAC; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROCODONE; HYDROCODONE BITARTRATE PLUS PARACETAMOL; HYDROMORPHONE; IBUPROFEN; KETOROLAC; MELOXICAM; METHADONE; MISOPROSTOL; MONOAMINE OXIDASE INHIBITOR; MORPHINE; MUSCLE RELAXANT AGENT; NABUMETONE; NAPROXEN; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; PARACETAMOL; PIROXICAM; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SULINDAC; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ANALGESIA; CARDIOTOXICITY; CARDIOVASCULAR RISK; CONSTIPATION; DIZZINESS; GASTROINTESTINAL TOXICITY; HEADACHE; HEART INFARCTION; HUMAN; LIVER TOXICITY; LOW BACK PAIN; NAUSEA; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SEDATION; SELF CARE; SIDE EFFECT; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT;

ANALGESICS; ANALGESICS, OPIOID; ANTICOAGULANTS; ANTIDEPRESSIVE AGENTS; CHRONIC DISEASE; EVIDENCE-BASED MEDICINE; HUMANS; LOW BACK PAIN; NEUROMUSCULAR AGENTS;

EID: 84865840330     PISSN: 00954543     EISSN: 1558299X     Source Type: Journal    
DOI: 10.1016/j.pop.2012.06.005     Document Type: Review

References (43)

1. Prevalence and most common causes of disability among adults-United States, 2005. MMWR Morb Mortal Wkly Rep 2009, 58(16):421-426. Available at:, Accessed February 8, 2012. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5816a2.htm.
2. AAPM facts and figures on pain 2012, American Academy of Pain Medicine, Available at:, Accessed February 8, 2012. http://www.painmed.org/patient/facts.html.
3. A call to revolutionize chronic pain care in America: an opportunity in health care reform 2012, The Mayday Fund, Available at:, Accessed February 8, 2012. mailto:http://www.maydaypainreport.org/docs/A%2520Call%2520to%2520Revolutionize%2520Chronic%2520Pain%2520Care%2520in%2520America%252003.04.10.pdf.
4. Duffy R.L. Low back pain: an approach to diagnosis and management. Prim Care Clin Office Pract 2010, 37:729-741.
5. Kincade S. Evaluation and treatment of acute low back pain. Am Fam Physician 2007, 75:1181-1188.
6. Laine C., Goldmann D., Wilson J.F. In the clinic: low back pain. Arch Intern Med 2008, 148. ITC5-1-ITC5-16.
7. Last A.R., Kulber K. Chronic low back pain: evaluation and management. Am Fam Physician 2009, 79:1067-1074.
8. Chou R., Qaseem A., Snow V., et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 2007, 147:478-491.
9. Chou R., Fanciullo G.J., Fine P.G., et al. Clinical guidelines for the use of chronic opioid therapy for chronic noncancer pain. J Pain 2009, 10:113-130.
10. Deyo R.A., Weinstein J.N. Low back pain. N Engl J Med 2001, 344:363-370.
11. Williams C.M., Latimer J., Maher C.G., et al. PACE-the first placebo controlled trial of paracetamol for acute low back pain: design of a randomized controlled trial. BMC Musculoskelet Disord 2010, 11:169.
12. Questions and answers about oral prescription acetaminophen products to be limited to 321 mg per dosage unit 2012, Food and Drug Administration, Available at:, Accessed February 8, 2012. http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm239871.htm.
13. Nourjah P., Ahmad S.R., Karwoski C., et al. Estimates of acetaminophen (paracetamol)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf 2006, 15:398-405.
14. Roelofs P.D., Deyo R.A., Koes B.W., et al. Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev 2008, (1). CD000396.
15. Burke A., Smyth E., FitzGerald G.A. Analgesic-antipyretic agents; pharmacotherapy of gout. Goodman & Gilman's the pharmacological basis of therapeutics 2006, 671-717. McGraw - Hill, New York. 11th edition. L. Brunton, J. Lazo, K. Parker (Eds.).
16. Ejaz P., Bhojani K., Joshi V.R. NSAIDs and kidney. J Assoc Physicians India 2004, 52:632-640.
17. Cryer B. NSAID-associated deaths: the rise and fall of NSAID-associated GI mortality. Am J Gastroenterol 2005, 100:1694-1695.
18. Rostom A., Muir K., Dube C., et al. Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors. Drug Healthc Patient Saf 2009, 1:47-71.
19. Fosbol E.L., Folke F., Jacobson S., et al. Cause-specific cardiovascular risk associated with nonsteroidal antiinflammatory drugs among healthy individuals. Circ Cardiovasc Qual Outcomes 2010, 3:395-405.
20. Graham D.J. COX-2 inhibitors, other NSAIDs, and cardiovascular risk: the seduction of common sense. JAMA 2006, 296:1653-1656.
21. Ray W.A., Varas-Lorenzo C., Chung C.P., et al. Cardiovascular risks of nonsteroidal anti-inflammatory drugs in patients after hospitalization for serious coronary heart disease. Circ Cardiovasc Qual Outcomes 2009, 2:155-163.
22. McGettigan P., Henry D. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of select and nonselective inhibitors of cyclooxygenase-2. JAMA 2006, 296:1633-1644.
23. Lee T. Pharmacologic treatment for low back pain: one component of pain care. Phys Med Rehabil Clin N Am 2010, 21:793-800.
24. Deshpande A., Furlan A.D., Mailis-Gagnon A., et al. Opioids for chronic low-back pain. Cochrane Database Syst Rev 2007, (3). CD004959.
25. Lexicomp online. Tramadol 2012, Lexi-Comp Inc, Hudson (OH).
26. Gutstein H.B., Akil H. Opioid analgesics. Goodman & Gilman's the pharmacological basis of therapeutics 2006, 547-591. McGraw - Hill, New York. 11th edition. L. Brunton, J. Lazo, K. Parker (Eds.).
27. WHO's pain ladder. HO stepwise pain management 2012, World Health Organization, Available at:, Accessed February 8, 2012. http://www.who.int/cancer/palliative/painladder/en/.
28. van Tulder M.W., Touray T., Furlan A.D., et al. Muscle relaxants for non-specific low-back pain. Cochrane Database Syst Rev 2003, (4). CD004252.
29. Lexicomp online. Carisoprodal 2012, Lexi-Comp Inc, Hudson (OH).
30. Lexicomp online. Dantrolene 2012, Lexi-Comp Inc, Hudson (OH).
31. Lexicomp online. Tizanidine 2012, Lexi-Comp Inc, Hudson (OH).
32. Fick D.M., Cooper J.W., Wade W.E., et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003, 163:2716-2724.
33. Urquhart D.M., Hoving J.L., Assendelft W.J., et al. Antidepressants for non-specific low back pain. Cochrane Database Syst Rev 2008, (1). CD001703.
34. Lunn M.P., Hughes R.A., Wiffen P.J. Duloxetine for treating painful neuropathy or chronic pain. Cochrane Database Syst Rev 2009, (4). CD007115.
35. Skljarevski V., Desaiah D., Liu-Seifert H., et al. Efficacy and safety of duloxetine in patients with chronic low back pain (CLBP-1). Spine 2010, 35:E578-E585.
36. Skljarevski V., Ossanna M., Liu-Seifert H., et al. A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain (CLBP-2). Eur J Neurol 2009, 16:1041-1048.
37. Skljarevski V., Zhang S., Desaiah D., et al. Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial (CLBP-3). J Pain 2010, 11:1282-1290.
38. Seidel S., Aigner M., Ossege M., et al. Antipsychotics for acute and chronic pain in adults. Cochrane Database Syst Rev 2008, (4).
39. Lexicomp online. Gabapentin 2012, Lexi-Comp Inc, Hudson (OH).
40. Lexicomp online. Carbamazepine 2012, Lexi-Comp Inc, Hudson (OH).
41. Romano C.L., Romano D., Bonora C., et al. Pregabalin, celecoxib, and their combination for treatment of chronic low back pain. J Orthop Traumatol 2009, 10:185-191.
42. Gimble J., Linn R., Hale M., et al. Lidocaine patch treatment in patients with low back pain: results of an open label, non randomized pilot study. Am J Ther 2005, 12:311-319.
43. IOM (Institute of Medicine) Relieving pain in America: a blueprint for transforming prevention, care, education and research 2011, The National Academies Press, Washington, DC.